Alembic Pharmaceuticals gets USFDA nod for ophthalmic solution

New Delhi: Drug firm Alembic Pharmaceuticals Monday said it has received approval from the US health regulator for Olopatadine Hydrochloride ophthalmic solution, used to treat allergic conjunctivitis. The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Olopatadine Hydrochloride ophthalmic solution USP, 0.1 per cent, Alembic Pharmaceuticals said in a filing to BSE.

The approved product is therapeutically equivalent to the reference listed drug product (RLD) Patanol ophthalmic solution, 0.1 per cent, of Novartis Pharmaceuticals Corporation, the company added.

Quoting IQVIA data, Alembic Pharma said Olopatadine Hydrochloride ophthalmic solution has an estimated market size of USD 61 million for 12 months ending December 2017.

The company said it currently has 83 ANDA approvals from USFDA.

Shares of Alembic Pharmaceuticals were trading 0.07 per cent lower at Rs 614 apiece on BSE.

  • Related Posts

    Two nurses at AIIMS Bhopal booked for giving wrong injection to child cancer patient that caused his death

    The nurses have been booked under BNS Sections 106 and 286 at the Bagsewania police station. While Ms. Sharma allegedly administered the wrong injection, Ms. Gujarati had left the toxic…

    Telangana DCA unearths Rs 70.56-lakh excipient label-tampering scam

    Telangana: In a major enforcement action targeting the pharmaceutical supply chain, the Drugs Control Administration (DCA) in Telangana has busted a sophisticated racket involving the illegal label-tampering and misrepresentation of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Two nurses at AIIMS Bhopal booked for giving wrong injection to child cancer patient that caused his death

    Two nurses at AIIMS Bhopal booked for giving wrong injection to child cancer patient that caused his death

    Telangana DCA unearths Rs 70.56-lakh excipient label-tampering scam

    Telangana DCA unearths Rs 70.56-lakh excipient label-tampering scam

    ‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

    ‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

    Price cap on 2 key cancer drugs increased by 50%

    Price cap on 2 key cancer drugs increased by 50%

    Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

    Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

    IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

    IIT Bhubaneswar researchers develop portable device for accurate arsenic detection